Oncovir品牌介绍
Oncovir品牌介绍
品牌简介
Oncovir,Inc是一家制药公司,致力于开发基于核酸的临床疗法,用于治疗癌症、传染性疾病、免疫疾病和退行性疾病。
我们提倡Hiltonol®(poly ICLC)作为一种实验性病毒模拟物和广泛的先天性和适应性免疫激活剂。Hiltonol®最初是作为干扰素诱导剂开发的,但在人体内具有更广泛的生物学效应,包括特异性抗病毒、免疫激活、疫苗佐剂和抗肿瘤作用。
Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders.
We promote Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. While initially developed as an interferon inducer, Hiltonol® has much broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions
Main product
Hiltonol’s®
https://www.oncovir.com
联系我们
相关推荐
评论列表共有 0 条评论
暂无评论
发表评论
取消回复
药科美专注生命科学产品进出口与技术服务